The Association Between Dermatomyositis and Papillary Thyroid Cancer: a Case Report

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2011 Jan 19

PMID 21243494

Citations 3

Authors

Tokunori Ikeda

En Kimura

Teruyuki Hirano

Makoto Uchino

Affiliations

Soon will be listed here.

Abstract

We report the case of a 66-year-old woman who developed progressive proximal muscle weakness and papillary thyroid cancer. After a thyroidectomy, she was treated with intravenous methylprednisolone pulse therapy and oral prednisolone followed by tacrolimus therapy. However, her clinical symptoms and laboratory data did not improve sufficiently. Therefore, we administered intravenous immunoglobulin. As a result, she regained substantial muscle strength along with complete normalization of serum muscle enzymes and showed no evidence of recurrence of papillary thyroid cancer or exacerbation of dermatomyositis (DM). Although there is controversy as to whether papillary thyroid cancer is involved in DM, the results of this study support a connection between these two conditions.

Citing Articles

Mixed connective tissue and ovarian cancer: a case report.

Kudsi M, Khalayli N, Hola L, Aldeeb M, Aziz A Ann Med Surg (Lond). 2024; 86(1):467-471.

PMID: 38222766 PMC: 10783415. DOI: 10.1097/MS9.0000000000001462.

A Recurrent Episode of Dermatomyositis Associated with Papillary Thyroid Cancer.

Eranki V Case Rep Endocrinol. 2017; 2017:7985953.

PMID: 28804657 PMC: 5539940. DOI: 10.1155/2017/7985953.

Mixed Connective Tissue Disease and Papillary Thyroid Cancer: A Case Report.

Thongpooswan S, Tushabe R, Song J, Kim P, Abrudescu A Am J Case Rep. 2015; 16:517-9.

PMID: 26245523 PMC: 4530986. DOI: 10.12659/AJCR.894176.

References

Elovaara I, Apostolski S, van Doorn P, Gilhus N, Hietaharju A, Honkaniemi J . EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008; 15(9):893-908. DOI: 10.1111/j.1468-1331.2008.02246.x. View

Dietrich L, Bridges A, Albertini M . Dermatomyositis after interferon alpha treatment. Med Oncol. 2000; 17(1):64-9. DOI: 10.1007/BF02826219. View

Li X, Li H, Chen J, He Q, Lv R, Lin W . Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol Dial Transplant. 2007; 23(6):1919-25. DOI: 10.1093/ndt/gfm637. View

Niewold T, Kariuki S, Morgan G, Shrestha S, Pachman L . Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum. 2009; 60(6):1815-24. PMC: 2697261. DOI: 10.1002/art.24555. View

Fujita M, Hatachi S, Yagita M . Dermatomyositis associated with thyroid cancer. Rheumatol Int. 2008; 29(2):203-5. DOI: 10.1007/s00296-008-0642-4. View

Hatada T, Aoki I, Ikeda H, Tamura T, Okada K, Nakai T . Dermatomyositis and malignancy: case report and review of the Japanese literature. Tumori. 1996; 82(3):273-5. View

Siegal F, Kadowaki N, Shodell M, Shah K, Ho S, Antonenko S . The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999; 284(5421):1835-7. DOI: 10.1126/science.284.5421.1835. View

Greenberg S, Pinkus J, Pinkus G, Burleson T, Sanoudou D, Tawil R . Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005; 57(5):664-78. DOI: 10.1002/ana.20464. View

Hill C, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A . Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001; 357(9250):96-100. DOI: 10.1016/S0140-6736(00)03540-6. View

10.

Lee J, Kim S . A case of dermatomyositis associated with papillary cancer of the thyroid gland. Clin Rheumatol. 2004; 24(4):437-8. DOI: 10.1007/s10067-004-0979-3. View

11.

Charles J, Chaperot L, Salameire D, Di Domizio J, Aspord C, Gressin R . Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Eur J Dermatol. 2009; 20(1):16-23. PMC: 2881955. DOI: 10.1684/ejd.2010.0816. View

12.

Lopez De Padilla C, Reed A . Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2008; 20(6):669-74. DOI: 10.1097/BOR.0b013e3283157538. View

13.

Mitsui T, Kuroda Y, Kunishige M, Matsumoto T . Successful treatment with tacrolimus in a case of refractory dermatomyositis. Intern Med. 2005; 44(11):1197-9. DOI: 10.2169/internalmedicine.44.1197. View

14.

Nagashima T, Onishi S, Kamata Y, Minota S . Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?. Rheumatol Int. 2009; 29(10):1261-2. DOI: 10.1007/s00296-009-0858-y. View

15.

Dalakas M, Illa I, Dambrosia J, Soueidan S, Stein D, Otero C . A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993; 329(27):1993-2000. DOI: 10.1056/NEJM199312303292704. View